Ixovex-1

N/A

Report date: 2025/03/04 14:50:28

Base Information

Drug NameIxovex-1
Drug Alias NameOncolytic human adenovirus serotype 5Ixovex-1
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPsivac Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPsivac Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A